ResBiotech is an Innovation Institute for cardio-respiratory and maternal-child health technologies.
Our world-class team and research partners are dedicated to the innovation, incubation, acceleration and commercialization of state of the art technologies with world-wide health impacts.
Novel drugs for lung and
Smart devices for monitoring, diagnostics and management
analytics for R&D
Innovate: Cutting edge cardio-respiratory & maternal-child health research is both done in house and sourced from local and national partners.
Incubate: ResBiotech incubates scientific research with real world applications and zeroes in on market opportunity.
Accelerate: ResBiotech brings software and AI, data and analytics, licensing, regulatory, and other resources to bear to accelerate the path to market.
Commercialize: ResBiotech spins out state of the art technologies with worldwide health impacts and return on investment.
A Platform for Commercialization and Spin-Offs
Respiratory Probiotic and Pharmacobiotics
Inhalers, Smart ICU
A Hub to Deliver Coaching and Services for Caregivers
Benchmarking, National Registries, Outcome Prediction